*Some Market data delayed by 15 mins.

OptiNose, Inc. Common Stock

Symbol: OPTN (NASDAQ)
1.32 ▲ (10.50%) 0.125

Company Description:
OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.

Key Stats
  • Today's Open: $1.18
  • Today's High: $1.315
  • Today's Low: $1.16
  • Today's Volume: 688.86K
  • Yesterday Close: $1.19
  • Yesterday High: $1.215
  • Yesterday Low: $1.1001
  • Yesterday Volume: 458.99K
  • Last Min Volume: 1
  • Last Min High: $1.315
  • Last Min Low: $1.315
  • Last Min VWAP: $1.315
Company Profile
  • Name: OptiNose, Inc. Common Stock
  • Website: https://www.optinose.com
  • Listed Date: 2017-10-13
  • Location: YARDLEY, PA
  • Market Status: Active
  • CIK Number: 0001494650
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $143.56M
  • Round Lot: 100
  • Outstanding Shares: 113.04M
  • Asset Type: CS
RECENT FILINGS FOR OPTN
Filing DateFiling TypeFormat
2024-06-204View
2024-06-204View
2024-06-184View
2024-06-184View
2024-06-074View
2024-06-074View
2024-06-074View
2024-06-074View
2024-06-074View
2024-06-074View
2024-06-074View
2024-06-068-KView
2024-05-29SC 13G/AView
2024-05-208-KView
2024-05-20DView
2024-05-1410-QView
2024-05-148-KView
2024-05-09424B5View
2024-05-098-KView
2024-05-09424B5View
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.